Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications

The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years, significant progress has been made in oncological therapy, in systemic treatment, and in radiotherapy of breast cancer. Unfortunately, the improvement...

Full description

Saved in:
Bibliographic Details
Published inESC Heart Failure Vol. 8; no. 4; pp. 2397 - 2418
Main Authors Bikiewicz, Agata, Banach, Maciej, Haehling, Stephan, Maciejewski, Marek, Bielecka‐Dabrowa, Agata
Format Journal Article
LanguageEnglish
Published England John Wiley & Sons, Inc 01.08.2021
John Wiley and Sons Inc
Wiley
Subjects
Antibiotics
Apoptosis
Biomarkers
Breast cancer
Cancer therapies
Cardiac arrhythmia
Cardiomyocytes
Cardiotoxicity
Chemotherapy
Drug dosages
Epidermal growth factor
Genetic engineering
Heart failure
Hormone replacement therapy
Kinases
Mammography
Monoclonal antibodies
Myocarditis
Oncological treatment
Radiation therapy
Review
Reviews
Womens health
Heart failure
Biomarkers
Breast cancer
Cardiotoxicity
Oncological treatment
Online AccessGet full text

Cover

Abstract The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years, significant progress has been made in oncological therapy, in systemic treatment, and in radiotherapy of breast cancer. Unfortunately, the improvement in the effectiveness of oncological treatment and prolonging patients' life span is associated with more frequent occurrence of organ complications, which are side effects of this treatment. Current recommendations suggest a periodic monitoring of the cardiovascular system in course of oncological treatment. The monitoring includes the assessment of occurrence of risk factors for cardiovascular diseases in combination with the evaluation of the left ventricular systolic function using echocardiography and electrocardiography as well as with the analysis of the concentration of cardiac biomarkers. The aim of this review was critical assessment of the breast cancer therapy cardiotoxicity and the analysis of methods its detections. The new cardio‐specific biomarkers in serum, the development of modern imaging techniques (Global Longitudinal Strain and Three‐Dimensional Left Ventricular Ejection Fraction) and genotyping, and especially their combined use, may become a useful tool for identifying patients at risk of developing cardiotoxicity, who require further cardiovascular monitoring or cardioprotective therapy.
AbstractList The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years, significant progress has been made in oncological therapy, in systemic treatment, and in radiotherapy of breast cancer. Unfortunately, the improvement in the effectiveness of oncological treatment and prolonging patients' life span is associated with more frequent occurrence of organ complications, which are side effects of this treatment. Current recommendations suggest a periodic monitoring of the cardiovascular system in course of oncological treatment. The monitoring includes the assessment of occurrence of risk factors for cardiovascular diseases in combination with the evaluation of the left ventricular systolic function using echocardiography and electrocardiography as well as with the analysis of the concentration of cardiac biomarkers. The aim of this review was critical assessment of the breast cancer therapy cardiotoxicity and the analysis of methods its detections. The new cardio-specific biomarkers in serum, the development of modern imaging techniques (Global Longitudinal Strain and Three-Dimensional Left Ventricular Ejection Fraction) and genotyping, and especially their combined use, may become a useful tool for identifying patients at risk of developing cardiotoxicity, who require further cardiovascular monitoring or cardioprotective therapy.
Abstract The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years, significant progress has been made in oncological therapy, in systemic treatment, and in radiotherapy of breast cancer. Unfortunately, the improvement in the effectiveness of oncological treatment and prolonging patients' life span is associated with more frequent occurrence of organ complications, which are side effects of this treatment. Current recommendations suggest a periodic monitoring of the cardiovascular system in course of oncological treatment. The monitoring includes the assessment of occurrence of risk factors for cardiovascular diseases in combination with the evaluation of the left ventricular systolic function using echocardiography and electrocardiography as well as with the analysis of the concentration of cardiac biomarkers. The aim of this review was critical assessment of the breast cancer therapy cardiotoxicity and the analysis of methods its detections. The new cardio‐specific biomarkers in serum, the development of modern imaging techniques (Global Longitudinal Strain and Three‐Dimensional Left Ventricular Ejection Fraction) and genotyping, and especially their combined use, may become a useful tool for identifying patients at risk of developing cardiotoxicity, who require further cardiovascular monitoring or cardioprotective therapy.
Abstract The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years, significant progress has been made in oncological therapy, in systemic treatment, and in radiotherapy of breast cancer. Unfortunately, the improvement in the effectiveness of oncological treatment and prolonging patients' life span is associated with more frequent occurrence of organ complications, which are side effects of this treatment. Current recommendations suggest a periodic monitoring of the cardiovascular system in course of oncological treatment. The monitoring includes the assessment of occurrence of risk factors for cardiovascular diseases in combination with the evaluation of the left ventricular systolic function using echocardiography and electrocardiography as well as with the analysis of the concentration of cardiac biomarkers. The aim of this review was critical assessment of the breast cancer therapy cardiotoxicity and the analysis of methods its detections. The new cardio‐specific biomarkers in serum, the development of modern imaging techniques (Global Longitudinal Strain and Three‐Dimensional Left Ventricular Ejection Fraction) and genotyping, and especially their combined use, may become a useful tool for identifying patients at risk of developing cardiotoxicity, who require further cardiovascular monitoring or cardioprotective therapy.
Author Bielecka‐Dabrowa, Agata
Banach, Maciej
Bikiewicz, Agata
Haehling, Stephan
Maciejewski, Marek
AuthorAffiliation 2 Department of Hypertension, Chair of Nephrology and Hypertension Medical University of Lodz Lodz Poland
4 Department of Cardiology and Congenital Diseases of Adults Polish Mother's Memorial Hospital Research Institute (PMMHRI) Lodz Poland
1 Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults Polish Mother's Memorial Hospital Research Institute (PMMHRI) Rzgowska 281/289 Lodz 93‐338 Poland
3 Department of Cardiology and Pneumology and German Center for Cardiovascular Research (DZHK), partner site Göttingen University Medical Center Göttingen (UMG) Göttingen Germany
AuthorAffiliation_xml – name: 4 Department of Cardiology and Congenital Diseases of Adults Polish Mother's Memorial Hospital Research Institute (PMMHRI) Lodz Poland
– name: 3 Department of Cardiology and Pneumology and German Center for Cardiovascular Research (DZHK), partner site Göttingen University Medical Center Göttingen (UMG) Göttingen Germany
– name: 1 Heart Failure Unit, Department of Cardiology and Congenital Diseases of Adults Polish Mother's Memorial Hospital Research Institute (PMMHRI) Rzgowska 281/289 Lodz 93‐338 Poland
– name: 2 Department of Hypertension, Chair of Nephrology and Hypertension Medical University of Lodz Lodz Poland
Author_xml – sequence: 1
  givenname: Agata
  surname: Bikiewicz
  fullname: Bikiewicz, Agata
  email: pnserca@iczmp.edu.pl, agatbiel7@poczta.onet.pl
  organization: Medical University of Lodz
– sequence: 2
  givenname: Maciej
  surname: Banach
  fullname: Banach, Maciej
  organization: Medical University of Lodz
– sequence: 3
  givenname: Stephan
  surname: Haehling
  fullname: Haehling, Stephan
  organization: University Medical Center Göttingen (UMG)
– sequence: 4
  givenname: Marek
  surname: Maciejewski
  fullname: Maciejewski, Marek
  organization: Polish Mother's Memorial Hospital Research Institute (PMMHRI)
– sequence: 5
  givenname: Agata
  surname: Bielecka‐Dabrowa
  fullname: Bielecka‐Dabrowa, Agata
  organization: Medical University of Lodz
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33955207$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtrGzEUhUVJaR7Npj-gDHRXcKr3zGwKISRNINBNuxYa6SqWmZFcSXbjf1_Zk4Rk05V07z36rg7nFB2FGAChTwRfEIzpN1g6ekEYk-IdOqFYiIXoKD16dT9G5zmvMMZESCIo_4COGeuFoLg9QY-XdrXZ6lCaIYHOpTE6GEhNqVWZIJRcO8n6WOKjN77sGh1sM0ULKTQTlGW0uYmusVDAFB_DYb5OsK1v92WdHQDaNCZO69Ebve_nj-i902OG86fzDP2-uf51dbu4__nj7uryfmFER8Si7ZwU1hiptQPG7TAMfSsAt7KTvZSCceEGRqyxpOWSddySXlNmOme5a51lZ-hu5tqoV2qd_KTTTkXt1aER04PSqXgzgiKAGanMvmcDx7bvDOYUYGgxBywIr6zvM2u9GSawplpMenwDfTsJfqke4lZ1jHS8ZxXw5QmQ4p8N5KJWcZNC9a-oEEJWC1RW1ddZZVLMOYF72UCw2oeu9qGrQ-hV_Pn1n16kzxFXAZkFf_0Iu_-g1PXtDZ2h_wAzU7qq
CitedBy_id crossref_primary_10_3389_fphys_2023_1126057
crossref_primary_10_3390_ijms232415619
crossref_primary_10_1016_j_saa_2024_124623
crossref_primary_10_3389_fcvm_2024_1236966
crossref_primary_10_1016_j_biopha_2023_115373
crossref_primary_10_1016_j_ijcard_2023_131435
crossref_primary_10_3390_jcm11071792
crossref_primary_10_1186_s40959_022_00143_0
crossref_primary_10_1002_jmri_28667
crossref_primary_10_17116_kardio20221501140
crossref_primary_10_3390_antiox11061087
crossref_primary_10_1186_s12906_023_04104_7
crossref_primary_10_1152_japplphysiol_00504_2021
crossref_primary_10_3390_ijerph20010405
crossref_primary_10_1038_s41392_023_01469_6
crossref_primary_10_24969_hvt_2023_401
crossref_primary_10_1007_s10554_024_03101_2
crossref_primary_10_1002_ehf2_14377
crossref_primary_10_3390_cancers14020434
crossref_primary_10_1016_j_jaccao_2024_03_010
Cites_doi 10.1517/14728222.2013.733001
10.1200/JCO.2016.70.5400
10.1002/pbc.24505
10.1016/0006-291X(74)90601-9
10.1158/1940-6207.CAPR-11-0334
10.1186/1471-2407-10-337
10.1161/01.CIR.104.3.330
10.1007/s10549-012-2039-z
10.1016/j.jacc.2011.05.025
10.1016/j.ajem.2010.10.025
10.1053/j.seminoncol.2013.01.005
10.1056/NEJMoa0910383
10.1097/00001813-200109000-00001
10.1016/j.ijrobp.2017.05.030
10.1200/JCO.2005.12.157
10.1007/s10741-017-9653-0
10.6004/jnccn.2017.0044
10.1007/s00277-003-0615-3
10.1016/j.jacc.2012.07.067
10.1126/science.6093249
10.1016/j.jaccao.2019.08.006
10.1161/CIRCULATIONAHA.106.635144
10.18632/oncotarget.14355
10.2169/internalmedicine.44.120
10.1373/clinchem.2005.050153
10.1007/s12185-008-0112-5
10.1016/j.amjcard.2015.11.027
10.1016/j.ahj.2010.05.037
10.1161/CIRCRESAHA.112.267286
10.1097/MBC.0b013e3283597605
10.1200/JCO.2010.34.3467
10.1161/JAHA.120.018143
10.2174/1389200218666171101124931
10.1093/jrr/rrw064
10.1161/CIRCRESAHA.112.269035
10.1016/j.jccase.2019.08.005
10.1136/bcr-2015-209347
10.1200/JCO.2004.09.109
10.1200/JCO.2008.17.3203
10.1016/S0002-8703(98)70054-7
10.1038/35021093
10.1158/0008-5472.CAN-07-1649
10.1016/j.clinbiochem.2014.10.013
10.1182/blood.V68.5.1114.1114
10.1200/JCO.1993.11.7.1208
10.1007/s00280-011-1669-x
10.1016/S0140-6736(76)90151-3
10.5114/jcb.2014.47891
10.1016/j.ijrobp.2008.11.016
10.1136/postgradmedj-2016-134286
10.1038/clpt.2013.201
10.1161/CIRCULATIONAHA.113.002203
10.1038/35077225
10.7326/0003-4819-80-2-249
10.1093/jnci/djs317
10.1517/13543776.2016.1111872
10.1185/03007995.2012.707643
10.1200/JCO.2005.12.121
10.1038/sj.bjc.6605587
10.1038/nrc1317
10.1371/journal.pone.0096736
10.1016/S0735-1097(00)00748-8
10.3322/caac.21492
10.1093/annonc/mdz235
10.1136/heartjnl-2015-308765
10.1016/j.ijcard.2012.06.023
10.1038/nm.2919
10.1016/j.jacc.2009.03.095
10.1038/nrc3185
10.1016/j.leukres.2015.08.009
10.2165/00002018-200831060-00002
10.1056/NEJMra043186
10.1200/JCO.2007.13.5467
10.1016/j.jacc.2013.01.090
10.1016/j.clinbiochem.2013.03.014
10.1016/j.jjcc.2009.01.006
10.1002/clc.22872
10.1038/jhg.2013.42
10.1111/echo.13693
10.1016/j.ejcsup.2014.03.002
10.1016/j.jacc.2013.10.061
10.1093/ehjcr/ytz146
10.1016/j.jacc.2018.02.049
10.1007/s12012-007-0013-5
10.1089/ars.2012.5000
10.1186/s40169-017-0148-3
10.1161/CIRCULATIONAHA.110.950543
10.1016/j.cardfail.2013.12.018
10.1038/sj.bmt.1702234
10.1200/JCO.2009.26.7294
10.15420/cfr.2018.32.2
10.1007/s11912-016-0521-1
10.1002/ejhf.196
10.2459/JCM.0000000000000379
10.1016/j.ijrobp.2009.04.093
10.1038/sj.onc.1210477
10.1016/j.jacc.2012.09.035
10.1161/CIR.0000000000000556
10.1124/jpet.106.103846
10.1200/JCO.2015.65.6603
10.1373/clinchem.2015.241232
10.1016/j.annonc.2020.09.010
10.1016/j.ijcard.2013.01.005
10.1634/theoncologist.2008-0230
10.1007/s10549-017-4460-9
10.1186/2050-6511-15-47
10.3892/etm.2011.305
10.1177/1758835919864236
10.1161/CIRCULATIONAHA.111.021774
10.3389/fphar.2018.01262
10.1016/S0959-8049(01)00230-1
10.1152/japplphysiol.00148.2005
10.4103/0973-1482.37412
10.1200/JCO.2005.13.300
10.1016/S0140-6736(00)02051-1
10.1161/CIRCHEARTFAILURE.112.000055
10.1002/ejhf.1631
10.3892/ol.2016.4424
10.1517/14656566.8.8.1039
10.1158/1078-0432.CCR-09-0628
10.1016/j.bbadis.2012.12.014
10.2174/138920009788897975
10.1161/01.CIR.0000130926.51766.CC
10.1186/s13058-014-0446-2
10.1016/j.lfs.2018.12.018
10.1016/j.yjmcc.2003.09.012
10.1016/j.clon.2004.09.016
10.3233/CBM-181301
10.1097/01.COC.0000017526.55135.6D
10.1002/cncr.21478
10.1016/j.jcmg.2019.06.030
10.3109/0284186X.2013.781673
10.1158/1078-0432.CCR-10-1359
10.1016/S1470-2045(05)70251-5
10.1016/j.ijrobp.2007.05.034
10.1007/s10549-015-3437-9
10.1200/JCO.2007.15.9822
10.3322/caac.21557
10.1016/j.jccase.2017.03.009
10.3109/1354750X.2015.1040839
10.1080/10428194.2016.1231405
10.1016/S0046-8177(96)90447-5
10.1016/j.ijcard.2010.03.003
10.1016/j.biopha.2018.11.042
10.1093/annonc/mdt584
10.1016/j.amjcard.2018.08.019
10.1542/peds.2012-0727
10.1097/HCO.0000000000000050
10.1177/030089168206800609
10.1161/CIR.0000000000000679
10.1016/j.jacc.2013.02.072
10.2174/1568011023354146
10.7326/M19-2125
10.1093/annonc/mdq096
10.1093/eurheartj/ehw128
10.1007/s00280-015-2874-9
10.2174/0929867325666180327092639
10.1016/j.cell.2004.07.017
10.1093/ehjci/jeu192
10.1021/bi00700a012
10.1016/j.ygyno.2011.11.022
10.1093/eurheartj/ehw211
10.15420/icr.2019.12
10.1038/nature09783
10.1200/JCO.2005.05.827
10.1016/S0025-6196(11)60896-3
10.1016/j.annonc.2019.10.023
10.1016/j.ejca.2013.04.030
10.1186/s12885-018-4935-z
10.1093/cvr/cvq148
10.1016/j.taap.2014.10.006
10.1093/jrr/rry029
10.1161/CIRCULATIONAHA.115.020406
10.2147/BCTT.S176070
10.1016/j.clinthera.2009.11.029
10.1080/01926230500519816
10.1093/nar/gkn774
10.1517/14740338.2.1.59
10.1016/j.mayocp.2014.05.013
ContentType Journal Article
Copyright 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
– notice: 2021. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.1002/ehf2.13365
DatabaseName Wiley-Blackwell Open Access Collection
Wiley Free Archive
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database
PubMed

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
EISSN 2055-5822
EndPage 2418
ExternalDocumentID oai_doaj_org_article_1e031665993b40d98c042eeb704e0514
10_1002_ehf2_13365
33955207
EHF213365
Genre reviewArticle
Journal Article
Review
GrantInformation_xml – fundername: Polish National Agency for Academic Exchange
– fundername: ;
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8FI
8FJ
AAHHS
ABUWG
ACCFJ
ACXQS
ADBBV
ADKYN
ADZMN
ADZOD
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
EMOBN
FYUFA
GODZA
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
INH
KQ8
M~E
OK1
PIMPY
PQQKQ
PROAC
RPM
UKHRP
WIN
ITC
NPM
AAYXX
CITATION
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c5815-78f65dcc6aafe34dbbb975e076869665345fb31dcd1746384d19a23c8fd4f7fd3
IEDL.DBID RPM
ISSN 2055-5822
IngestDate Tue Oct 22 15:08:41 EDT 2024
Tue Sep 17 21:26:51 EDT 2024
Thu Oct 10 22:19:03 EDT 2024
Thu Sep 26 19:06:08 EDT 2024
Sat Sep 28 08:25:12 EDT 2024
Sat Aug 24 01:04:53 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Heart failure
Biomarkers
Breast cancer
Cardiotoxicity
Oncological treatment
Language English
License Attribution-NonCommercial
2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5815-78f65dcc6aafe34dbbb975e076869665345fb31dcd1746384d19a23c8fd4f7fd3
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318493/
PMID 33955207
PQID 2555674626
PQPubID 4368362
PageCount 22
ParticipantIDs doaj_primary_oai_doaj_org_article_1e031665993b40d98c042eeb704e0514
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8318493
proquest_journals_2555674626
crossref_primary_10_1002_ehf2_13365
pubmed_primary_33955207
wiley_primary_10_1002_ehf2_13365_EHF213365
PublicationCentury 2000
PublicationDate August 2021
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: August 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
– name: Hoboken
PublicationTitle ESC Heart Failure
PublicationTitleAlternate ESC Heart Fail
PublicationYear 2021
Publisher John Wiley & Sons, Inc
John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: John Wiley and Sons Inc
– name: Wiley
References 2004; 22
2010; 10
1974; 57
2012; 124
2006; 34
2019; 11
2013; 61
1993; 20
2019; 14
2013; 128
2015; 76
2010; 102
2008; 36
2004; 4
2014; 25
2012; 18
2018; 41
2020; 13
2014; 29
2008; 31
2011; 58
2012; 12
2016; 37
2013; 6
2016; 34
2014; 20
1982; 68
2018; 9
2009; 14
2010; 21
2012; 130
2011; 124
2013; 58
2009; 10
2012; 134
2019; 20
2005; 104
2019; 26
2020; 172
2000; 406
2007; 8
2014; 16
2014; 15
2008; 26
2013; 114
2013; 60
2007; 7
2012; 28
2007; 3
2017; 166
2010; 3
2014; 95
2007; 67
2011; 123
2011; 365
1998; 12
2014; 12
2018; 38
2001; 411
2007; 69
2009; 15
1971; 3
2010; 8
2010; 32
2019; 3
2011; 2
2019; 5
2000; 355
2019; 30
2019; 1
1984; 226
2002; 8
2003; 35
2002; 2
1976; 1
2010; 160
2011; 4
2016; 18
2018; 23
2012; 104
2016; 17
2011; 6
1998; 135
2012; 30
2006; 114
2016; 11
2018; 19
2018; 18
2012; 110
2012; 111
2009; 73
2020; 31
2017; 58
2015; 61
2015; 2015
2003; 26
2005; 6
2001; 37
2019; 218
2020; 22
2005; 17
2016; 26
2006; 100
2015; 35
2017; 6
2010; 55
2012; 60
2018; 122
1974; 13
2017; 8
2015; 39
2013; 24
2016; 107
2016; 102
2013; 167
2010; 144
2013; 168
2011; 15
2014; 63
2011; 17
2001; 104
2005; 23
2012; 53
2015; 48
2014; 4
2009; 54
2013; 17
2017; 39
1974; 80
2018; 137
2017; 35
2019; 69
2017; 34
2020; 9
2003; 2
2016; 117
2014; 281
2018; 71
2012; 69
2003; 82
2014; 9
2001; 12
1996; 27
2019; 112
2007; 26
2001; 10
2014; 53
2019; 110
2015; 2
2010; 76
2006; 318
2015; 17
2013; 49
2013; 1832
2000; 25
2012
2011
2010
2013; 46
2013; 40
2020; 77
2004; 109
2015; 7
2014; 89
2005; 44
2016; 57
2018; 68
2007; 357
2015; 152
2010; 87
2017; 93
2009; 31
2011; 469
2017; 15
2000; 36
2013; 35
2017; 16
2017; 11
1993; 11
2017; 99
1986; 68
2005; 51
2016; 133
2017; 18
2008; 88
2019; 139
2008; 83
2011; 49
2004; 118
2018; 59
e_1_2_5_23_1
e_1_2_5_46_1
e_1_2_5_162_1
e_1_2_5_185_1
e_1_2_5_124_1
e_1_2_5_101_1
e_1_2_5_109_1
e_1_2_5_61_1
e_1_2_5_84_1
Writing Group Members (e_1_2_5_198_1) 2016; 133
e_1_2_5_150_1
e_1_2_5_11_1
e_1_2_5_34_1
e_1_2_5_57_1
e_1_2_5_113_1
e_1_2_5_136_1
e_1_2_5_151_1
e_1_2_5_197_1
Yaylali YT (e_1_2_5_144_1) 2016; 107
e_1_2_5_19_1
e_1_2_5_159_1
e_1_2_5_72_1
e_1_2_5_95_1
Horacek JM (e_1_2_5_174_1) 2013; 114
e_1_2_5_146_1
e_1_2_5_169_1
e_1_2_5_45_1
e_1_2_5_184_1
e_1_2_5_123_1
e_1_2_5_22_1
e_1_2_5_68_1
O'Leary J (e_1_2_5_79_1) 1998; 12
e_1_2_5_60_1
e_1_2_5_83_1
e_1_2_5_172_1
e_1_2_5_206_1
Liu LK (e_1_2_5_98_1) 2017; 18
e_1_2_5_158_1
e_1_2_5_8_1
e_1_2_5_10_1
e_1_2_5_135_1
e_1_2_5_173_1
Rowinsky EK (e_1_2_5_85_1) 1993; 20
e_1_2_5_33_1
e_1_2_5_112_1
e_1_2_5_196_1
e_1_2_5_18_1
e_1_2_5_71_1
Hoon Tan P (e_1_2_5_7_1) 2020; 77
e_1_2_5_94_1
Choe JC (e_1_2_5_148_1) 2018; 41
Tsavaris N (e_1_2_5_77_1) 2002; 8
e_1_2_5_161_1
Barros MVL (e_1_2_5_145_1) 2019; 112
e_1_2_5_25_1
e_1_2_5_48_1
e_1_2_5_168_1
e_1_2_5_122_1
e_1_2_5_107_1
e_1_2_5_63_1
e_1_2_5_86_1
e_1_2_5_194_1
e_1_2_5_40_1
e_1_2_5_205_1
e_1_2_5_171_1
e_1_2_5_36_1
e_1_2_5_59_1
e_1_2_5_157_1
e_1_2_5_13_1
e_1_2_5_111_1
e_1_2_5_134_1
e_1_2_5_195_1
e_1_2_5_5_1
e_1_2_5_97_1
e_1_2_5_51_1
e_1_2_5_160_1
e_1_2_5_183_1
Liu L (e_1_2_5_128_1) 2013; 35
e_1_2_5_121_1
e_1_2_5_167_1
e_1_2_5_47_1
e_1_2_5_24_1
e_1_2_5_106_1
e_1_2_5_129_1
e_1_2_5_62_1
e_1_2_5_170_1
e_1_2_5_193_1
e_1_2_5_204_1
Horacek JM (e_1_2_5_175_1) 2010; 32
e_1_2_5_110_1
e_1_2_5_156_1
Killu A (e_1_2_5_74_1) 2011; 15
e_1_2_5_58_1
e_1_2_5_179_1
e_1_2_5_35_1
e_1_2_5_6_1
e_1_2_5_12_1
e_1_2_5_133_1
e_1_2_5_118_1
e_1_2_5_73_1
Tsiamis E (e_1_2_5_69_1) 2012; 53
e_1_2_5_50_1
e_1_2_5_182_1
e_1_2_5_27_1
e_1_2_5_166_1
e_1_2_5_189_1
e_1_2_5_120_1
e_1_2_5_143_1
e_1_2_5_65_1
e_1_2_5_88_1
e_1_2_5_105_1
e_1_2_5_80_1
Eldabaje R (e_1_2_5_108_1) 2015; 35
e_1_2_5_42_1
e_1_2_5_203_1
e_1_2_5_192_1
e_1_2_5_15_1
e_1_2_5_38_1
e_1_2_5_132_1
e_1_2_5_155_1
e_1_2_5_178_1
e_1_2_5_76_1
e_1_2_5_99_1
e_1_2_5_117_1
e_1_2_5_3_1
e_1_2_5_91_1
e_1_2_5_30_1
e_1_2_5_53_1
e_1_2_5_181_1
e_1_2_5_49_1
e_1_2_5_188_1
e_1_2_5_26_1
e_1_2_5_142_1
e_1_2_5_165_1
e_1_2_5_87_1
e_1_2_5_104_1
e_1_2_5_127_1
e_1_2_5_64_1
e_1_2_5_202_1
e_1_2_5_41_1
e_1_2_5_191_1
e_1_2_5_14_1
e_1_2_5_131_1
e_1_2_5_177_1
e_1_2_5_37_1
e_1_2_5_154_1
e_1_2_5_4_1
e_1_2_5_139_1
e_1_2_5_116_1
e_1_2_5_90_1
e_1_2_5_75_1
e_1_2_5_52_1
Dalen EC (e_1_2_5_119_1) 2011; 6
e_1_2_5_180_1
Wang Y (e_1_2_5_147_1) 2018; 38
Garibaldi C (e_1_2_5_100_1) 2017; 11
e_1_2_5_103_1
e_1_2_5_21_1
e_1_2_5_44_1
e_1_2_5_164_1
e_1_2_5_187_1
e_1_2_5_67_1
e_1_2_5_126_1
e_1_2_5_149_1
e_1_2_5_29_1
Dalen EC (e_1_2_5_114_1) 2010; 3
e_1_2_5_82_1
e_1_2_5_201_1
e_1_2_5_190_1
e_1_2_5_17_1
e_1_2_5_130_1
e_1_2_5_199_1
e_1_2_5_9_1
e_1_2_5_32_1
e_1_2_5_55_1
e_1_2_5_153_1
e_1_2_5_176_1
e_1_2_5_78_1
e_1_2_5_115_1
e_1_2_5_138_1
e_1_2_5_70_1
e_1_2_5_93_1
e_1_2_5_28_1
e_1_2_5_140_1
e_1_2_5_102_1
e_1_2_5_125_1
e_1_2_5_163_1
e_1_2_5_43_1
e_1_2_5_186_1
e_1_2_5_66_1
e_1_2_5_89_1
e_1_2_5_81_1
e_1_2_5_200_1
e_1_2_5_20_1
e_1_2_5_39_1
e_1_2_5_16_1
Santos GW (e_1_2_5_56_1) 1971; 3
Wang W (e_1_2_5_141_1) 2017; 39
e_1_2_5_54_1
e_1_2_5_2_1
e_1_2_5_137_1
Brand MD (e_1_2_5_96_1) 2001; 10
e_1_2_5_92_1
Cardinale D (e_1_2_5_152_1) 2011; 49
e_1_2_5_31_1
References_xml – volume: 167
  start-page: 2306
  year: 2013
  end-page: 2310
  article-title: Protective effects of nebivolol against anthracycline‐induced cardiomyopathy: a randomized control study
  publication-title: Int J Cardiol
– volume: 61
  start-page: 2319
  year: 2013
  end-page: 2328
  article-title: Cardiac complications of thoracic irradiation
  publication-title: J Am Coll Cardiol
– volume: 77
  start-page: 181
  year: 2020
  end-page: 185
  article-title: WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the breast
  publication-title: Histopathology
– volume: 99
  start-page: 182
  year: 2017
  end-page: 190
  article-title: Strain imaging detects dose‐dependent segmental cardiac dysfunction in the acute phase after breast irradiation
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 82
  start-page: 218
  year: 2003
  end-page: 222
  article-title: Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies
  publication-title: Ann Hematol
– volume: 39
  start-page: 1389
  year: 2015
  end-page: 1395
  article-title: The impact of standard chemotherapy on miRNA signature in plasma in AML patients
  publication-title: Leuk Res
– volume: 406
  start-page: 747
  year: 2000
  end-page: 752
  article-title: Molecular portraits of human breast tumours
  publication-title: Nature
– volume: 80
  start-page: 249
  year: 1974
  end-page: 259
  article-title: Adriamycin. A new anticancer drug with significant clinical activity
  publication-title: Ann Intern Med
– volume: 28
  start-page: 1263
  year: 2012
  end-page: 1279
  article-title: Systematic review of lapatinib in combination with letrozole compared with other first‐line treatments for hormone receptor positive (HR+) and HER2+ advanced or metastatic breast cancer (MBC)
  publication-title: Curr Med Res Opin
– volume: 11
  start-page: 1208
  year: 1993
  end-page: 1215
  article-title: Cardiac disease following treatment of Hodgkin's disease in children and adolescents
  publication-title: J Clin Oncol
– volume: 16
  start-page: 446
  year: 2014
  article-title: Risk determination and prevention of breast cancer
  publication-title: Breast Cancer Res
– volume: 137
  start-page: e30
  year: 2018
  end-page: e66
  article-title: American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association
  publication-title: Circulation
– volume: 102
  start-page: 269
  year: 2016
  end-page: 276
  article-title: Radiation‐induced valvular heart disease
  publication-title: Heart
– volume: 26
  start-page: 3958
  year: 2008
  article-title: Influence of pre‐and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study
  publication-title: J Clin Oncol
– volume: 37
  start-page: 2129
  year: 2016
  end-page: 2200
  article-title: 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
  publication-title: Eur Heart J
– volume: 76
  start-page: 957
  year: 2015
  end-page: 967
  article-title: Relationship of promising methods in the detection of anthracycline‐induced cardiotoxicity in breast cancer patients
  publication-title: Cancer Chemother Pharmacol
– volume: 20
  start-page: 155
  year: 2014
  end-page: 158
  article-title: Cancer therapy‐induced left ventricular dysfunction: interventions and prognosis
  publication-title: J Card Fail
– volume: 20
  start-page: 1
  year: 1993
  end-page: 15
  article-title: Clinical toxicities encountered with paclitaxel (Taxol)
  publication-title: Semin Oncol
– volume: 36
  start-page: 517
  year: 2000
  end-page: 522
  article-title: Left ventricular dysfunction predicted by early troponin I release after high dose chemotherapy
  publication-title: J Am Coll Cardiol
– volume: 25
  start-page: 885
  year: 2000
  end-page: 894
  article-title: Cardiac and pulmonary toxicity in patients undergoing high‐dose chemo‐therapy for lymphoma and breast cancer: prognostic factors
  publication-title: Bone Marrow Transplant
– volume: 109
  start-page: 2749
  year: 2004
  end-page: 2754
  article-title: Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high‐dose chemotherapy
  publication-title: Circulation
– volume: 3
  start-page: 400
  year: 1971
  end-page: 404
  article-title: Marrow transplanation in man following cyclophosphamide
  publication-title: Transplant Proc
– volume: 24
  start-page: 90
  year: 2013
  end-page: 94
  article-title: Takotsubo syndrome: an underdiagnosed complication of 5‐fluorouracil mimicking acute myocardial infarction
  publication-title: Blood Coagul Fibrinolysis
– volume: 53
  start-page: 65
  year: 2014
  end-page: 74
  article-title: Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial
  publication-title: Acta Oncol
– volume: 31
  start-page: 2332
  year: 2009
  end-page: 2348
  article-title: Lapatinib: a small‐molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor‐2 tyrosine kinases used in the treatment of breast cancer
  publication-title: Clin Ther
– volume: 117
  start-page: 691
  year: 2016
  end-page: 696
  article-title: Assessment of valvular disorders in survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy ± chemotherapy
  publication-title: Am J Cardiol
– volume: 124
  start-page: 642
  year: 2011
  end-page: 650
  article-title: Modulation of anthracycline‐induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms
  publication-title: Circulation
– volume: 68
  start-page: 394
  year: 2018
  end-page: 424
  article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J Clin
– volume: 1
  start-page: 58
  year: 1976
  end-page: 32
  article-title: Acute lethal carditis caused by high‐dose combination chemotherapy. A unique clinical and pathological entity
  publication-title: Lancet
– volume: 107
  start-page: 411
  year: 2016
  end-page: 419
  article-title: Atrial function in patients with breast cancer after treatment with anthracyclines
  publication-title: Arq Bras Cardiol
– volume: 104
  start-page: 1293
  year: 2012
  end-page: 1305
  article-title: Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study
  publication-title: J Natl Cancer Inst
– volume: 93
  start-page: 271
  year: 2017
  end-page: 274
  article-title: Alterations in the echocardiographic variables of the right ventricle in asymptomatic patients with breast cancer during anthracycline chemotherapy
  publication-title: Postgrad Med J
– volume: 357
  start-page: 39
  year: 2007
  end-page: 51
  article-title: Trastuzumab—mechanism of action and use in clinical practice
  publication-title: N Engl J Med
– volume: 20
  start-page: 1567
  year: 2014
  end-page: 1589
  article-title: Redox‐modulated phenomena and radiation therapy: the central role of superoxide dismutases
  publication-title: Antioxid Redox Signal
– volume: 100
  start-page: 519
  year: 2006
  end-page: 527
  article-title: Low‐intensity exercise training during doxorubicin treatment protects against cardiotoxicity
  publication-title: J Appl Physiol
– volume: 68
  start-page: 1114
  year: 1986
  end-page: 1118
  article-title: Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor
  publication-title: Blood
– volume: 35
  start-page: 936
  year: 2013
  end-page: 940
  article-title: Preventive effect of low‐dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer
  publication-title: Zhonghua Zhong Liu Za Zhi
– volume: 8
  start-page: 6994
  year: 2017
  end-page: 7002
  article-title: Circulating miR‐1 as a potential biomarker of doxorubicin‐induced cardiotoxicity in breast cancer patients
  publication-title: Oncotarget
– volume: 102
  start-page: 1003
  year: 2010
  end-page: 1009
  article-title: Influence of pharmacogenetics on response and toxicity in breast cancer patients treated with doxorubicin and cyclophosphamide
  publication-title: Br J Cancer
– volume: 469
  start-page: 336
  year: 2011
  end-page: 342
  article-title: Pervasive roles of microRNAs in cardiovascular biology
  publication-title: Nature
– volume: 41
  start-page: 349
  year: 2018
  end-page: 353
  article-title: Left atrial volume in patients with HER2‐positive breast cancer: one step further to predict trastuzumab‐related cardiotoxicity
  publication-title: Clin Cardiol
– volume: 63
  start-page: 809
  year: 2014
  end-page: 816
  article-title: Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab
  publication-title: J Am Coll Cardiol
– volume: 114
  start-page: 708
  year: 2013
  end-page: 710
  article-title: Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia
  publication-title: Bratisl Lek Listy
– volume: 11
  start-page: 1
  year: 2019
  end-page: 9
  article-title: Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER‐2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial
  publication-title: Ther Adv Med Oncol
– volume: 12
  start-page: 18
  year: 2014
  end-page: 28
  article-title: Cardiovascular disease after cancer therapy
  publication-title: EJC Suppl
– volume: 26
  start-page: 103
  year: 2003
  end-page: 106
  article-title: Severe toxicity related to the 5‐fluorouracil/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients
  publication-title: Am J Clin Oncol
– volume: 10
  start-page: 681
  year: 2001
  end-page: 685
  article-title: Radiation‐associated valvular heart disease in Hodgkin's disease is associated with characteristic thickening and fibrosis of the aortic‐mitral curtain
  publication-title: J Heart Valve Dis
– volume: 23
  start-page: 2900
  year: 2005
  end-page: 2902
  article-title: Type II chemotherapy‐related cardiac dysfunction: time to recognize a new entity
  publication-title: J Clin Oncol
– volume: 13
  start-page: 1221
  year: 2020
  end-page: 1234
  article-title: Myocardial tissue characterization and fibrosis by imaging
  publication-title: JACC Cardiovasc Imaging
– volume: 34
  start-page: 2743
  year: 2016
  end-page: 2749
  article-title: Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer
  publication-title: J Clin Oncol
– volume: 226
  start-page: 466
  year: 1984
  end-page: 468
  article-title: Adriamycin‐induced DNA damage mediated by mammalian DNA topoisomerase II
  publication-title: Science
– volume: 35
  start-page: 1473
  year: 2003
  end-page: 1479
  article-title: Neuregulin‐1 protects ventricular myocytes from anthracycline‐induced apoptosis via erbB4‐dependent activation of PI3‐kinase/Akt
  publication-title: J Mol Cell Cardiol
– volume: 17
  start-page: 81
  year: 2015
  end-page: 89
  article-title: Protective effects of spironolactone against anthracycline‐induced cardiomyopathy
  publication-title: Eur J Heart Fail
– volume: 88
  start-page: 227
  year: 2008
  end-page: 236
  article-title: Cardiac toxicity of high‐dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
  publication-title: Int J Hematol
– volume: 365
  start-page: 1273
  year: 2011
  end-page: 1283
  article-title: Adjuvant trastuzumab in HER2‐positive breast cancer
  publication-title: N Engl J Med
– volume: 128
  start-page: 152
  year: 2013
  end-page: 161
  article-title: An engineered bivalent neuregulin protects against doxorubicin‐induced cardiotoxicity with reduced proneoplastic potential
  publication-title: Circulation
– volume: 14
  start-page: 320
  year: 2009
  end-page: 368
  article-title: The HER‐2 receptor and breast cancer: ten years of targeted anti‐HER‐2 therapy and personalized medicine
  publication-title: Oncologist
– volume: 54
  start-page: 330
  year: 2009
  end-page: 334
  article-title: Fulminant fatal cardiotoxicity following cyclophosphamide therapy
  publication-title: J Cardiol
– volume: 49
  start-page: 1937
  year: 2011
  end-page: 1948
  article-title: Role of biomarkers in cardio‐oncology
  publication-title: ClinChem Lab Med
– volume: 5
  start-page: 112
  year: 2019
  end-page: 118
  article-title: Heart failure and cancer: mechanisms of old and new cardiotoxic drugs in cancer patients
  publication-title: Card Fail Rev
– volume: 36
  start-page: 6825
  year: 2008
  end-page: 6834
  article-title: Interaction of anthracyclines with iron responsive element mRNAs
  publication-title: Nucleic Acids Res
– volume: 123
  start-page: 391
  year: 2011
  end-page: 399
  article-title: Distinct effects of leukocyte and cardiac phosphoinositide 3‐kinase γ activity in pressure overload‐induced cardiac failure
  publication-title: Circulation
– volume: 12
  start-page: 104
  year: 2012
  end-page: 120
  article-title: Balancing repair and tolerance of DNA damage caused by alkylating agents
  publication-title: Nat Rev Cancer
– volume: 7
  start-page: 67
  year: 2007
  end-page: 71
  article-title: Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes
  publication-title: Cardiovasc Toxicol
– volume: 112
  start-page: 50
  year: 2019
  end-page: 56
  article-title: Left ventricular regional wall motion abnormality is a strong predictor of cardiotoxicity in breast cancer patients undergoing chemotherapy
  publication-title: Arq Bras Cardiol
– volume: 46
  start-page: 1013
  year: 2013
  end-page: 1019
  article-title: NT‐proANP and NT‐proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies
  publication-title: Clin Biochem
– volume: 110
  start-page: 1465
  year: 2012
  end-page: 1473
  article-title: MicroRNA‐mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes
  publication-title: Circ Res
– volume: 166
  start-page: 927
  year: 2017
  end-page: 936
  article-title: Cardiac toxicities of lapatinib in patients with breast cancer and other HER2‐positive cancers: a meta‐analysis
  publication-title: Breast Cancer Res Treat
– volume: 61
  start-page: 2355
  year: 2013
  end-page: 2362
  article-title: Enalapril and carvedilol for preventing chemotherapy‐induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies)
  publication-title: J Am Coll Cardiol
– volume: 130
  start-page: 1003
  year: 2012
  end-page: 1011
  article-title: Dana‐Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium. Continuous versus bolus infusion of doxorubicin in children with all: long‐term cardiac outcomes
  publication-title: Pediatrics
– volume: 58
  start-page: 988
  year: 2011
  end-page: 989
  article-title: Efficiency of atorvastatin in the protection of anthracycline‐induced cardiomyopathy
  publication-title: J Am Coll Cardiol
– volume: 76
  start-page: S77
  year: 2010
  end-page: S85
  article-title: Radiation dose‐volume effects in the heart
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 49
  start-page: 2900
  year: 2013
  end-page: 2909
  article-title: Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta‐analysis
  publication-title: Eur J Cancer
– volume: 110
  start-page: 1
  year: 2019
  end-page: 8
  article-title: Plasmatic and chamber‐specific modulation of cardiac microRNAs in an acute model of DOX‐induced cardiotoxicity
  publication-title: Biomed Pharmacother
– volume: 57
  start-page: 439
  year: 2016
  end-page: 448
  article-title: Pathology and biology of radiation‐induced cardiac disease
  publication-title: J Radiat Res
– volume: 21
  start-page: 2153
  year: 2010
  end-page: 2160
  article-title: Efficacy and cardiac safety of adjuvant trastuzumab‐based chemotherapy regimens for HER2‐positive early breast cancer
  publication-title: Ann Oncol
– volume: 10
  start-page: 470
  year: 2009
  end-page: 481
  article-title: Tyrosine kinase inhibitors ‐ a review on pharmacology, metabolism and side effects
  publication-title: Curr Drug Metab
– volume: 16
  start-page: 26
  year: 2017
  end-page: 29
  article-title: A case of ventricular fibrillation as a consequence of capecitabine‐induced secondary QT prolongation: A case report
  publication-title: J Cardiol Cases
– volume: 1832
  start-page: 2442
  year: 2013
  end-page: 2450
  article-title: Biomarkers and diagnostics in heart failure
  publication-title: Biochim Biophys Acta
– volume: 411
  start-page: 355
  year: 2001
  end-page: 365
  article-title: Oncogenic kinase signalling
  publication-title: Nature
– volume: 2
  start-page: 59
  year: 2003
  end-page: 71
  article-title: Cardiotoxic effects of anthracycline‐taxane combinations
  publication-title: Expert Opin Drug Saf
– volume: 111
  start-page: 1376
  issue: 10
  year: 2012
  end-page: 1385
  article-title: Neuregulin in cardiovascular development and disease
  publication-title: Circulation Research
– volume: 59
  start-page: 291
  year: 2018
  end-page: 297
  article-title: Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer—comparison of four‐field technique and traditional two opposed fields technique
  publication-title: J Radiat Res
– volume: 22
  start-page: 350
  year: 2020
  end-page: 361
  article-title: Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta‐analysis
  publication-title: Eur J Heart Fail
– volume: 7
  start-page: 23
  year: 2015
  end-page: 28
  article-title: Comparison of radiation dose to the left anterior descending artery by whole and partial breast irradiation in breast cancer patients
  publication-title: J Contemp Brachytherapy
– volume: 1
  start-page: 54
  year: 2019
  end-page: 65
  article-title: Efficacy of neurohormonal therapies in preventing cardiotoxicity in patients with cancer undergoing chemotherapy
  publication-title: JACC Cardio Oncol
– volume: 14
  start-page: 89
  year: 2019
  end-page: 94
  article-title: Coronary artery vasospasm induced by 5‐fluorouracil: proposed mechanisms, existing management options and future directions
  publication-title: Interv Cardiol
– volume: 133
  start-page: 38
  year: 2016
  end-page: 360
  article-title: American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics‐2016 Update: A Report From the American Heart Association
  publication-title: Circulation
– volume: 48
  start-page: 223
  year: 2015
  end-page: 235
  article-title: Use of biomarkers for the assessment of chemotherapy‐induced cardiac toxicity
  publication-title: Clin Biochem
– volume: 71
  start-page: 2281
  year: 2018
  end-page: 2290
  article-title: Carvedilol for prevention of chemotherapy‐related cardiotoxicity: the CECCY trial
  publication-title: J Am Coll Cardiol
– volume: 87
  start-page: 656
  year: 2010
  end-page: 664
  article-title: Acute doxorubicin cardiotoxicity is associated with miR‐146a‐induced inhibition of the neuregulin‐ErbB pathway
  publication-title: Cardiovasc Res
– volume: 61
  start-page: 77
  year: 2013
  end-page: 84
  article-title: Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy
  publication-title: J Am Coll Cardiol
– volume: 26
  start-page: 1231
  year: 2008
  end-page: 1238
  article-title: Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial
  publication-title: J Clin Oncol
– volume: 53
  start-page: 320
  year: 2012
  end-page: 323
  article-title: Capecitabine may induce coronary artery vasospasm
  publication-title: Hellenic J Cardiol
– volume: 8
  start-page: 3429
  year: 2010
  end-page: 3436
  article-title: Role of three‐dimensional echocardiography in breast cancer: comparison with two‐dimensional echocardiography, multiple‐gated acquisition scans, and cardiac magnetic resonance imaging
  publication-title: J Clin Oncol
– volume: 4
  start-page: 47
  year: 2014
  article-title: A systematic review of the pathophysiology of 5‐fluorouracil‐induced cardiotoxicity
  publication-title: BMC Pharmacol Toxicol
– volume: 9
  year: 2014
  article-title: BNP predicts chemotherapy‐related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography
  publication-title: PLoS One
– volume: 55
  start-page: 213
  year: 2010
  end-page: 220
  article-title: Anthracycline‐induced cardiomyopathy: clinical relevance and response to pharmacologic therapy
  publication-title: J Am Coll Cardiol
– volume: 15
  start-page: 433
  year: 2017
  end-page: 451
  article-title: NCCN guidelines insights: breast cancer, version 1.2017
  publication-title: J Natl Compr Canc Netw
– volume: 31
  start-page: 171
  year: 2020
  end-page: 190
  article-title: Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
  publication-title: Ann Oncol
– volume: 15
  start-page: 4963
  year: 2009
  end-page: 4967
  article-title: Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training
  publication-title: Clin Cancer Res
– volume: 34
  start-page: 94
  year: 2006
  end-page: 104
  article-title: Serum chemical biomarkers of cardiac injury for nonclinical safety testing
  publication-title: Toxicol Pathol
– volume: 160
  start-page: 487.e1
  year: 2010
  end-page: 487.e7
  article-title: Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin‐induced inflammation, oxidative stress, and early ventricular impairment
  publication-title: Am Heart J
– volume: 134
  start-page: 291
  year: 2012
  end-page: 298
  article-title: High‐sensitivity C‐reactive protein (hs‐CRP) as a biomarker for trastuzumab‐induced cardiotoxicity in HER2‐positive early‐stage breast cancer: a pilot study
  publication-title: Breast Cancer Res Treat
– volume: 218
  start-page: 112
  year: 2019
  end-page: 131
  article-title: Molecular mechanism involved in cyclophosphamide‐induced cardiotoxicity: Old drug with a new vision
  publication-title: Life Sci
– year: 2011
– volume: 318
  start-page: 424
  year: 2006
  end-page: 433
  article-title: Paclitaxel and docetaxel stimulation of doxo‐rubicinol formation in the human heart: implications for cardio‐toxicity of doxorubicin‐taxane chemotherapies
  publication-title: J Pharmacol Exp Ther
– volume: 355
  start-page: 805
  year: 2000
  end-page: 806
  article-title: QT dispersion as a predictor of acute heart failure after high‐dose cyclophosphamide
  publication-title: Lancet
– volume: 18
  start-page: 583
  year: 2017
  end-page: 587
  article-title: Pathogenesis and prevention of radiation‐induced myocardial fibrosis
  publication-title: Asian Pac J Cancer Prev
– volume: 11
  start-page: 785
  year: 2017
  article-title: Recent advances in radiation oncology
  publication-title: Ecance Mmed Sci
– volume: 152
  start-page: 67
  year: 2015
  end-page: 76
  article-title: Clinical and genetic risk factors for epirubicin‐induced cardiac toxicity in early breast cancer patients
  publication-title: Breast Cancer Res Treat
– volume: 4
  start-page: 1149
  year: 2011
  end-page: 1157
  article-title: Targeting the HER/EGFR/ErbB family to prevent breast cancer
  publication-title: Cancer Prev Res
– volume: 3
  year: 2010
  article-title: Different anthracycline derivates for reducing cardiotoxicity in cancer patients
  publication-title: Cochrane Database Syst Rev
– volume: 60
  start-page: 1375
  year: 2013
  end-page: 1381
  article-title: CPNDS consortium validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children
  publication-title: Pediatr Blood Cancer
– volume: 104
  start-page: 330
  year: 2001
  end-page: 335
  article-title: Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo
  publication-title: Circulation
– volume: 25
  start-page: 628
  year: 2014
  end-page: 632
  article-title: BRENDA study group. The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects
  publication-title: Ann Oncol
– volume: 135
  start-page: 914
  year: 1998
  end-page: 923
  article-title: Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
  publication-title: Am Heart J
– volume: 3
  start-page: 169
  year: 2007
  end-page: 171
  article-title: Transient asymptomatic bradycardia in patients on infusional 5‐fluorouracil
  publication-title: J Cancer Res Ther
– volume: 8
  start-page: 1039
  year: 2007
  end-page: 1058
  article-title: Anthracycline‐induced cardiotoxicity: course, pathophysiology, prevention and management
  publication-title: Expert Opin Pharmacother
– volume: 118
  start-page: 375
  year: 2004
  end-page: 387
  article-title: PI3Kγ modulates the cardiac response to chronic pressure overload by distinct kinase‐dependent and ‐independent effects
  publication-title: Cell
– volume: 37
  start-page: 2768
  year: 2016
  end-page: 2801
  article-title: 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The: Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
  publication-title: Eur Heart J
– volume: 26
  start-page: 1
  year: 2016
  end-page: 20
  article-title: Taxane anticancer agents: a patent perspective
  publication-title: Expert Opin Ther Pat
– volume: 32
  start-page: 97
  year: 2010
  end-page: 99
  article-title: The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high‐dose chemotherapy for acute leukemia
  publication-title: Exp Oncol
– volume: 17
  start-page: 153
  year: 2005
  end-page: 159
  article-title: Cardiac complications of radiation therapy
  publication-title: Clin Oncol
– volume: 2015
  year: 2015
  article-title: 5‐Fluorouracil cardiotoxicity: reversible left ventricular systolic dysfunction with early detection
  publication-title: BMJ Case Rep
– volume: 133
  start-page: 1104
  year: 2016
  end-page: 1114
  article-title: Shared risk factors in cardiovascular disease and cancer
  publication-title: Circulation
– volume: 17
  start-page: 3490
  year: 2011
  end-page: 3499
  article-title: Troponin I and C‐reactive protein are commonly detected in patients with breast cancer treated with dose‐dense chemotherapy incorporating trastuzumab and lapatinib
  publication-title: Clin Cancer Res
– volume: 9
  start-page: 1262
  year: 2018
  article-title: Updates in anthracycline‐mediated cardiotoxicity
  publication-title: Front Pharmacol
– volume: 44
  start-page: 120
  year: 2005
  end-page: 123
  article-title: Cyclophosphamide‐induced cardiomyopathy in a patient with seminoma and a history of mediastinal irradiation
  publication-title: Intern Med
– volume: 6
  start-page: 420
  year: 2013
  end-page: 426
  article-title: Cardioprotective effect of β‐adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow‐up study of heart failure
  publication-title: Circ Heart Fail
– volume: 67
  start-page: 8839
  year: 2007
  end-page: 8846
  article-title: Topoisomerase IIbeta mediated DNA double‐strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
  publication-title: Cancer Res
– volume: 60
  start-page: 2384
  year: 2012
  end-page: 2390
  article-title: Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study
  publication-title: J Am Coll Cardiol
– volume: 12
  start-page: 23
  year: 1998
  end-page: 27
  article-title: Taxanes in adjuvant and neoadjuvant therapies for breast cancer
  publication-title: Oncology (Williston Park)
– volume: 83
  start-page: 679
  year: 2008
  end-page: 686
  article-title: Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials
  publication-title: Mayo Clin Proc
– volume: 9
  year: 2020
  article-title: Cardiotoxicity and cardiovascular biomarkers in patients with breast cancer: data from the GeparOcto‐GBG 84 trial
  publication-title: J Am Heart Assoc
– volume: 23
  start-page: 2629
  year: 2005
  end-page: 2636
  article-title: Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia
  publication-title: J ClinOncol
– volume: 26
  start-page: 6469
  year: 2007
  end-page: 6487
  article-title: The oncogene HER2; its signaling and transforming functions and its role in human cancer pathogenesis
  publication-title: Oncogene
– volume: 23
  start-page: 7820
  year: 2005
  end-page: 7826
  article-title: Reversibility of trastuzumab‐related cardiotoxicity: new insights based on clinical course and response to medical treatment
  publication-title: J Clin Oncol
– volume: 35
  start-page: 2487
  year: 2015
  end-page: 2492
  article-title: Radiation‐associated cardiac injury
  publication-title: Anticancer Res
– year: 2010
– volume: 2
  start-page: 267
  year: 2002
  end-page: 310
  article-title: The prodrugs of 5‐fluorouracil
  publication-title: Curr Med Chem Anticancer Agents
– volume: 144
  start-page: 3
  year: 2010
  end-page: 15
  article-title: Cardiac side‐effects of cancer chemotherapy
  publication-title: Int J Cardiol
– volume: 58
  start-page: 1197
  year: 2017
  end-page: 1206
  article-title: Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
  publication-title: Leuk Lymphoma
– volume: 168
  start-page: 2120
  year: 2013
  end-page: 2126
  article-title: Clinical utility of N‐terminal pro‐B‐type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT‐proBNP risk score
  publication-title: Int J Cardiol
– volume: 31
  start-page: 459
  year: 2008
  end-page: 467
  article-title: Cardiotoxicity profile of trastuzumab
  publication-title: Drug Saf
– volume: 2
  start-page: 143
  year: 2015
  end-page: 148
  article-title: New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide
  publication-title: Biomarkers
– volume: 39
  start-page: 835
  year: 2017
  end-page: 840
  article-title: Early detection of the cardiotoxicity induced by chemotherapy drug through two‐dimensional speckle tracking echocardiography combined with high‐sensitive cardiac troponin T
  publication-title: ZhonghuaZhong Liu ZaZhi
– volume: 17
  start-page: 27
  year: 2016
  end-page: 34
  article-title: Role of biomarkers in monitoring antiblastic cardiotoxicity. Special issue on cardiotoxicity from antiblastic drugs and cardioprotection
  publication-title: J Cardiovasc Med
– volume: 15
  start-page: 1063
  year: 2014
  end-page: 1093
  article-title: Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  publication-title: Eur Heart J Cardiovasc Imaging
– volume: 68
  start-page: 505
  year: 1982
  end-page: 510
  article-title: Cardiac toxicity of 5‐fluorouracil: a study on 1083 patients
  publication-title: Tumori
– volume: 73
  start-page: 980
  year: 2009
  end-page: 987
  article-title: Radiation‐induced cardiac toxicity after therapy for breast cancer: interaction between treatment era and follow‐up duration
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 104
  start-page: 2492
  year: 2005
  end-page: 2498
  article-title: Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone
  publication-title: Cancer
– volume: 6
  year: 2011
  article-title: Cardioprotective interventions for cancer patients receiving anthracyclines
  publication-title: Cochrane Database Syst Rev
– volume: 6
  start-page: 17
  year: 2017
  article-title: Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
  publication-title: Clin Transl Med
– volume: 30
  start-page: 1541
  year: 2019
  end-page: 1557
  article-title: Estimating the benefits of therapy for early‐stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer
  publication-title: Ann Oncol
– volume: 15
  year: 2011
  article-title: 5‐fluorouracil induced pericarditis
  publication-title: BMJ Case Rep
– volume: 23
  start-page: 2502
  year: 2005
  end-page: 2512
  article-title: Study of the biologic effects of lapatinib, a reversible inhibitor of ErbB1 and ErbB2 tyrosine kinases, on tumor growth and survival pathways in patients with advanced malignancies
  publication-title: J Clin Oncol
– volume: 4
  start-page: 253
  year: 2004
  end-page: 265
  article-title: Microtubules as a target for anticancer drugs
  publication-title: Nat Rev Cancer
– volume: 30
  start-page: 1422
  year: 2012
  end-page: 1428
  article-title: Canadian pharmacogenomics network for drug safety consortium pharmacogenomic prediction of anthracycline‐induced cardiotoxicity in children
  publication-title: J ClinOncol
– volume: 114
  start-page: 2474
  year: 2006
  end-page: 2481
  article-title: Prevention of high‐dose chemotherapy‐induced cardiotoxicity in high‐risk patients by angiotensin‐converting enzyme inhibition
  publication-title: Circulation
– volume: 27
  start-page: 766
  year: 1996
  end-page: 773
  article-title: Pathology of radiation‐induced heart disease: a surgical and autopsy study of 27 cases
  publication-title: Hum Pathol
– volume: 38
  start-page: 1032
  year: 2018
  end-page: 1038
  article-title: Evaluation of changes in right ventricular myocardial mechanical properties in breast cancer patients receiving pirarubicin using three‐dimensional speckle tracking imaging
  publication-title: Nan Fang Yi Ke Da XueXueBao
– volume: 281
  start-page: 221
  year: 2014
  end-page: 229
  article-title: Early biomarkers of doxorubicin‐induced heart injury in a mouse model
  publication-title: Toxicol Appl Pharmacol
– volume: 95
  start-page: 45
  year: 2014
  end-page: 52
  article-title: Topoisomerase 2β: a promising molecular target for primary prevention of anthracycline‐induced cardiotoxicity
  publication-title: Clin Pharmacol Ther
– volume: 8
  start-page: I51
  year: 2002
  end-page: I57
  article-title: Cardiotoxicity following different doses and schedules of 5‐fluorouracil administration for malignancy—a survey of 427 patients
  publication-title: Med Sci Monit
– volume: 58
  start-page: 346
  year: 2013
  end-page: 352
  article-title: Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity
  publication-title: J Hum Genet
– volume: 69
  start-page: 1484
  year: 2007
  end-page: 1495
  article-title: Cardiac exposures in breast cancer radiotherapy: 1950s‐1990s
  publication-title: Int J Radiat Oncol Biol Phys
– volume: 20
  start-page: 183
  year: 2019
  end-page: 186
  article-title: Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracil
  publication-title: J Cases
– volume: 122
  start-page: 1784
  year: 2018
  end-page: 1789
  article-title: Usefulness of global longitudinal strain for early identification of subclinical left ventricular dysfunction in patients with active cancer
  publication-title: Am J Cardiol
– volume: 18
  start-page: 1037
  year: 2018
  article-title: Two‐dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline‐trastuzumab chemotherapy in patients with breast cancer
  publication-title: BMC Cancer
– volume: 18
  start-page: 6
  year: 2016
  article-title: Fluoropyrimidine‐Induced Cardiotoxicity: Manifestations, Mechanisms, and Management
  publication-title: Curr Oncol Rep
– volume: 17
  start-page: 61
  year: 2013
  end-page: 75
  article-title: Targeting the Bcl‐2 family for cancer therapy
  publication-title: Expert Opin Ther Targets
– volume: 51
  start-page: 1405
  year: 2005
  end-page: 1410
  article-title: N‐terminal pro‐B‐type natriuretic peptide after high‐dose chemotherapy: a marker predictive of cardiac dysfunction?
  publication-title: Clin Chem
– volume: 57
  start-page: 689
  year: 1974
  end-page: 695
  article-title: Purification and amino acid analysis of an active site peptide from thymidylate synthetase containing covalently bound 5‐fluoro‐2′‐deoxyuridylate and methylenetetrahydrofolate
  publication-title: Biochem Biophys Res Commun
– volume: 30
  start-page: 257
  year: 2012
  end-page: 253
  article-title: Initial dose effect of 5‐fluorouracil: rapidly improving severe, acute toxic myopericarditis
  publication-title: Am J Emerg Med
– volume: 172
  start-page: 46
  year: 2020
  end-page: 56
  article-title: European Commission Initiative on Breast Cancer (ECIBC) Contributor Group. Breast cancer screening and diagnosis: a synopsis of the European breast guidelines
  publication-title: Ann Intern Med
– volume: 10
  start-page: 337
  year: 2010
  article-title: Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta‐analysis of randomised controlled trials
  publication-title: BMC Cancer
– volume: 11
  start-page: 151
  year: 2019
  end-page: 164
  article-title: Epidemiological characteristics of and risk factors for breast cancer in the world
  publication-title: Breast Cancer (Dove Med Press)
– volume: 69
  start-page: 57
  year: 2012
  end-page: 64
  article-title: 5‐fluorouracil‐based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity
  publication-title: Cancer Chemother Pharmacol
– volume: 3
  start-page: 1
  year: 2019
  end-page: 6
  article-title: Fluorouracil‐induced Takotsubo cardiomyopathy causing cardiogenic shock: a case report of clinical and acute cardiac magnetic resonance imaging features
  publication-title: Eur Heart J Case Rep
– volume: 22
  start-page: 3139
  year: 2004
  end-page: 3148
  article-title: Cardiovascular status in long‐term survivors of Hodgkin's disease treated with chest radiotherapy
  publication-title: J Clin Oncol
– volume: 18
  start-page: 1639
  year: 2012
  end-page: 1642
  article-title: Identification of the molecular basis of doxorubicin‐induced cardiotoxicity
  publication-title: Nat Med
– volume: 35
  start-page: 893
  year: 2017
  end-page: 911
  article-title: Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline
  publication-title: J ClinOncol
– volume: 41
  start-page: 1308
  year: 2018
  end-page: 1314
  article-title: Prolonged electromechanical delay as an early predictor of trastuzumab‐induced cardiotoxicity in patients undergoing treatment for breast cancer
  publication-title: ClinCardiol
– volume: 26
  start-page: 3288
  year: 2008
  article-title: Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer
  publication-title: J Clin Oncol
– volume: 31
  start-page: 1623
  year: 2020
  end-page: 1649
  article-title: ESO‐ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 5)
  publication-title: Ann Oncol
– volume: 2
  start-page: 1003
  year: 2011
  end-page: 1009
  article-title: Long‐term protective effects of the angiotensin receptor blocker telmisartan on epirubicin‐induced inflammation, oxidative stress and myocardial dysfunction
  publication-title: Exp Ther Med
– volume: 23
  start-page: 473
  year: 2018
  end-page: 484
  article-title: Correlation of circulating pro‐angiogenic miRNAs with cardiotoxicity induced by epirubicin/cyclophosphamide followed by docetaxel in patients with breast cancer
  publication-title: Cancer Biomark
– volume: 6
  start-page: 557
  year: 2005
  end-page: 565
  article-title: Long‐term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries
  publication-title: Lancet Oncol
– year: 2012
– volume: 11
  start-page: 3483
  year: 2016
  end-page: 3492
  article-title: Serum B‐type natriuretic peptide levels as a marker for anthracycline‐induced cardiotoxicity
  publication-title: Oncol Lett
– volume: 89
  start-page: 1287
  year: 2014
  end-page: 1306
  article-title: Evaluation and management of patients with heart disease and cancer: cardio‐oncology
  publication-title: Mayo Clin Proc
– volume: 37
  start-page: 3
  year: 2001
  end-page: 8
  article-title: The EGFR family and its ligands in human cancer
  publication-title: Eur J Cancer
– volume: 13
  start-page: 471
  year: 1974
  end-page: 481
  article-title: Mechanism of interaction of thymidylate synthetase with 5‐fluorodeoxyuridylate
  publication-title: Biochemistry
– volume: 23
  start-page: 109
  year: 2018
  end-page: 122
  article-title: Role of microRNAs in doxorubicin‐induced cardiotoxicity: an overview of preclinical models and cancer patients
  publication-title: Heart Fail Rev
– volume: 69
  start-page: 184
  year: 2019
  end-page: 210
  article-title: Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening
  publication-title: CA Cancer J Clin
– volume: 61
  start-page: 1164
  year: 2015
  end-page: 1172
  article-title: Longitudinal changes in multiple biomarkers are associated with cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab
  publication-title: Clin Chem
– volume: 124
  start-page: 575
  year: 2012
  end-page: 581
  article-title: Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane‐based chemotherapy: a Gynecologic Oncology Group study
  publication-title: Gynecol Oncol
– volume: 29
  start-page: 207
  year: 2014
  end-page: 213
  article-title: Macro advances in microRNAs and myocardial regeneration
  publication-title: Curr Opin Cardiol
– volume: 34
  start-page: 1601
  year: 2017
  end-page: 1609
  article-title: Early assessment of the left ventricular function by epirubicin‐induced cardiotoxicity in postoperative breast cancer patients
  publication-title: Echocardiography
– volume: 19
  start-page: 55
  year: 2018
  end-page: 74
  article-title: Pharmacogenetics of metabolic genes of anthracyclines in acute myeloid leukemia
  publication-title: Curr Drug Metab
– volume: 26
  start-page: 1155
  year: 2019
  end-page: 1184
  article-title: ABC transporters in extrahepatic tissues: pharmacological regulation in heart and intestine
  publication-title: Curr Med Chem
– volume: 12
  start-page: 639
  year: 2001
  end-page: 646
  article-title: Capecitabine: a novel agent for the treatment of solid tumors
  publication-title: Anticancer Drugs
– volume: 40
  start-page: 229
  year: 2013
  end-page: 238
  article-title: Asymptomatic cardiac toxicity in long‐term cancer survivors: defining the population and recommendations for surveillance
  publication-title: Semin Oncol
– volume: 139
  start-page: e997
  year: 2019
  end-page: e1012
  article-title: Cardio‐oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association
  publication-title: Circulation
– ident: e_1_2_5_82_1
  doi: 10.1517/14728222.2013.733001
– ident: e_1_2_5_134_1
  doi: 10.1200/JCO.2016.70.5400
– ident: e_1_2_5_193_1
  doi: 10.1002/pbc.24505
– ident: e_1_2_5_60_1
  doi: 10.1016/0006-291X(74)90601-9
– ident: e_1_2_5_31_1
  doi: 10.1158/1940-6207.CAPR-11-0334
– volume: 39
  start-page: 835
  year: 2017
  ident: e_1_2_5_141_1
  article-title: Early detection of the cardiotoxicity induced by chemotherapy drug through two‐dimensional speckle tracking echocardiography combined with high‐sensitive cardiac troponin T
  publication-title: ZhonghuaZhong Liu ZaZhi
  contributor:
    fullname: Wang W
– ident: e_1_2_5_111_1
  doi: 10.1186/1471-2407-10-337
– ident: e_1_2_5_22_1
  doi: 10.1161/01.CIR.104.3.330
– ident: e_1_2_5_171_1
  doi: 10.1007/s10549-012-2039-z
– ident: e_1_2_5_130_1
  doi: 10.1016/j.jacc.2011.05.025
– volume: 3
  start-page: 400
  year: 1971
  ident: e_1_2_5_56_1
  article-title: Marrow transplanation in man following cyclophosphamide
  publication-title: Transplant Proc
  contributor:
    fullname: Santos GW
– ident: e_1_2_5_73_1
  doi: 10.1016/j.ajem.2010.10.025
– ident: e_1_2_5_109_1
  doi: 10.1053/j.seminoncol.2013.01.005
– volume: 32
  start-page: 97
  year: 2010
  ident: e_1_2_5_175_1
  article-title: The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high‐dose chemotherapy for acute leukemia
  publication-title: Exp Oncol
  contributor:
    fullname: Horacek JM
– ident: e_1_2_5_39_1
  doi: 10.1056/NEJMoa0910383
– ident: e_1_2_5_61_1
  doi: 10.1097/00001813-200109000-00001
– ident: e_1_2_5_139_1
  doi: 10.1016/j.ijrobp.2017.05.030
– ident: e_1_2_5_48_1
  doi: 10.1200/JCO.2005.12.157
– ident: e_1_2_5_181_1
  doi: 10.1007/s10741-017-9653-0
– ident: e_1_2_5_9_1
  doi: 10.6004/jnccn.2017.0044
– ident: e_1_2_5_156_1
  doi: 10.1007/s00277-003-0615-3
– ident: e_1_2_5_202_1
  doi: 10.1016/j.jacc.2012.07.067
– ident: e_1_2_5_15_1
  doi: 10.1126/science.6093249
– ident: e_1_2_5_200_1
  doi: 10.1016/j.jaccao.2019.08.006
– ident: e_1_2_5_122_1
  doi: 10.1161/CIRCULATIONAHA.106.635144
– volume: 3
  year: 2010
  ident: e_1_2_5_114_1
  article-title: Different anthracycline derivates for reducing cardiotoxicity in cancer patients
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: Dalen EC
– volume: 15
  year: 2011
  ident: e_1_2_5_74_1
  article-title: 5‐fluorouracil induced pericarditis
  publication-title: BMJ Case Rep
  contributor:
    fullname: Killu A
– ident: e_1_2_5_177_1
  doi: 10.18632/oncotarget.14355
– ident: e_1_2_5_54_1
  doi: 10.2169/internalmedicine.44.120
– ident: e_1_2_5_160_1
  doi: 10.1373/clinchem.2005.050153
– volume: 112
  start-page: 50
  year: 2019
  ident: e_1_2_5_145_1
  article-title: Left ventricular regional wall motion abnormality is a strong predictor of cardiotoxicity in breast cancer patients undergoing chemotherapy
  publication-title: Arq Bras Cardiol
  contributor:
    fullname: Barros MVL
– ident: e_1_2_5_176_1
  doi: 10.1007/s12185-008-0112-5
– ident: e_1_2_5_97_1
  doi: 10.1016/j.amjcard.2015.11.027
– ident: e_1_2_5_124_1
  doi: 10.1016/j.ahj.2010.05.037
– ident: e_1_2_5_35_1
  doi: 10.1161/CIRCRESAHA.112.267286
– ident: e_1_2_5_66_1
  doi: 10.1097/MBC.0b013e3283597605
– ident: e_1_2_5_192_1
  doi: 10.1200/JCO.2010.34.3467
– ident: e_1_2_5_164_1
  doi: 10.1161/JAHA.120.018143
– ident: e_1_2_5_189_1
  doi: 10.2174/1389200218666171101124931
– ident: e_1_2_5_101_1
  doi: 10.1093/jrr/rrw064
– ident: e_1_2_5_184_1
  doi: 10.1161/CIRCRESAHA.112.269035
– ident: e_1_2_5_70_1
  doi: 10.1016/j.jccase.2019.08.005
– ident: e_1_2_5_75_1
  doi: 10.1136/bcr-2015-209347
– ident: e_1_2_5_104_1
  doi: 10.1200/JCO.2004.09.109
– ident: e_1_2_5_106_1
  doi: 10.1200/JCO.2008.17.3203
– ident: e_1_2_5_159_1
  doi: 10.1016/S0002-8703(98)70054-7
– ident: e_1_2_5_8_1
  doi: 10.1038/35021093
– ident: e_1_2_5_121_1
  doi: 10.1158/0008-5472.CAN-07-1649
– ident: e_1_2_5_153_1
  doi: 10.1016/j.clinbiochem.2014.10.013
– ident: e_1_2_5_57_1
  doi: 10.1182/blood.V68.5.1114.1114
– ident: e_1_2_5_107_1
  doi: 10.1200/JCO.1993.11.7.1208
– volume: 35
  start-page: 936
  year: 2013
  ident: e_1_2_5_128_1
  article-title: Preventive effect of low‐dose carvedilol combined with candesartan on the cardiotoxicity of anthracycline drugs in the adjuvant chemotherapy of breast cancer
  publication-title: Zhonghua Zhong Liu Za Zhi
  contributor:
    fullname: Liu L
– volume: 41
  start-page: 1308
  year: 2018
  ident: e_1_2_5_148_1
  article-title: Prolonged electromechanical delay as an early predictor of trastuzumab‐induced cardiotoxicity in patients undergoing treatment for breast cancer
  publication-title: ClinCardiol
  contributor:
    fullname: Choe JC
– ident: e_1_2_5_65_1
  doi: 10.1007/s00280-011-1669-x
– volume: 114
  start-page: 708
  year: 2013
  ident: e_1_2_5_174_1
  article-title: Glycogen phosphorylase BB as a potential marker of cardiac toxicity in patients treated with anthracyclines for acute leukemia
  publication-title: Bratisl Lek Listy
  contributor:
    fullname: Horacek JM
– ident: e_1_2_5_52_1
  doi: 10.1016/S0140-6736(76)90151-3
– volume: 10
  start-page: 681
  year: 2001
  ident: e_1_2_5_96_1
  article-title: Radiation‐associated valvular heart disease in Hodgkin's disease is associated with characteristic thickening and fibrosis of the aortic‐mitral curtain
  publication-title: J Heart Valve Dis
  contributor:
    fullname: Brand MD
– ident: e_1_2_5_93_1
  doi: 10.5114/jcb.2014.47891
– ident: e_1_2_5_94_1
  doi: 10.1016/j.ijrobp.2008.11.016
– ident: e_1_2_5_146_1
  doi: 10.1136/postgradmedj-2016-134286
– ident: e_1_2_5_120_1
  doi: 10.1038/clpt.2013.201
– ident: e_1_2_5_112_1
  doi: 10.1161/CIRCULATIONAHA.113.002203
– ident: e_1_2_5_28_1
  doi: 10.1038/35077225
– ident: e_1_2_5_14_1
  doi: 10.7326/0003-4819-80-2-249
– ident: e_1_2_5_42_1
  doi: 10.1093/jnci/djs317
– ident: e_1_2_5_80_1
  doi: 10.1517/13543776.2016.1111872
– ident: e_1_2_5_45_1
  doi: 10.1185/03007995.2012.707643
– ident: e_1_2_5_188_1
  doi: 10.1200/JCO.2005.12.121
– volume: 77
  start-page: 181
  year: 2020
  ident: e_1_2_5_7_1
  article-title: WHO Classification of Tumours Editorial Board. The 2019 WHO classification of tumours of the breast
  publication-title: Histopathology
  contributor:
    fullname: Hoon Tan P
– ident: e_1_2_5_195_1
  doi: 10.1038/sj.bjc.6605587
– ident: e_1_2_5_81_1
  doi: 10.1038/nrc1317
– ident: e_1_2_5_157_1
  doi: 10.1371/journal.pone.0096736
– ident: e_1_2_5_154_1
  doi: 10.1016/S0735-1097(00)00748-8
– ident: e_1_2_5_2_1
  doi: 10.3322/caac.21492
– ident: e_1_2_5_6_1
  doi: 10.1093/annonc/mdz235
– ident: e_1_2_5_95_1
  doi: 10.1136/heartjnl-2015-308765
– ident: e_1_2_5_127_1
  doi: 10.1016/j.ijcard.2012.06.023
– volume: 18
  start-page: 583
  year: 2017
  ident: e_1_2_5_98_1
  article-title: Pathogenesis and prevention of radiation‐induced myocardial fibrosis
  publication-title: Asian Pac J Cancer Prev
  contributor:
    fullname: Liu LK
– volume: 107
  start-page: 411
  year: 2016
  ident: e_1_2_5_144_1
  article-title: Atrial function in patients with breast cancer after treatment with anthracyclines
  publication-title: Arq Bras Cardiol
  contributor:
    fullname: Yaylali YT
– ident: e_1_2_5_13_1
  doi: 10.1038/nm.2919
– ident: e_1_2_5_30_1
  doi: 10.1016/j.jacc.2009.03.095
– ident: e_1_2_5_50_1
  doi: 10.1038/nrc3185
– volume: 6
  year: 2011
  ident: e_1_2_5_119_1
  article-title: Cardioprotective interventions for cancer patients receiving anthracyclines
  publication-title: Cochrane Database Syst Rev
  contributor:
    fullname: Dalen EC
– ident: e_1_2_5_179_1
  doi: 10.1016/j.leukres.2015.08.009
– ident: e_1_2_5_37_1
  doi: 10.2165/00002018-200831060-00002
– ident: e_1_2_5_36_1
  doi: 10.1056/NEJMra043186
– ident: e_1_2_5_40_1
  doi: 10.1200/JCO.2007.13.5467
– ident: e_1_2_5_88_1
  doi: 10.1016/j.jacc.2013.01.090
– ident: e_1_2_5_165_1
  doi: 10.1016/j.clinbiochem.2013.03.014
– ident: e_1_2_5_53_1
  doi: 10.1016/j.jjcc.2009.01.006
– ident: e_1_2_5_149_1
  doi: 10.1002/clc.22872
– ident: e_1_2_5_187_1
  doi: 10.1038/jhg.2013.42
– ident: e_1_2_5_140_1
  doi: 10.1111/echo.13693
– ident: e_1_2_5_91_1
  doi: 10.1016/j.ejcsup.2014.03.002
– ident: e_1_2_5_161_1
  doi: 10.1016/j.jacc.2013.10.061
– ident: e_1_2_5_67_1
  doi: 10.1093/ehjcr/ytz146
– ident: e_1_2_5_201_1
  doi: 10.1016/j.jacc.2018.02.049
– ident: e_1_2_5_86_1
  doi: 10.1007/s12012-007-0013-5
– volume: 49
  start-page: 1937
  year: 2011
  ident: e_1_2_5_152_1
  article-title: Role of biomarkers in cardio‐oncology
  publication-title: ClinChem Lab Med
  contributor:
    fullname: Cardinale D
– volume: 20
  start-page: 1
  year: 1993
  ident: e_1_2_5_85_1
  article-title: Clinical toxicities encountered with paclitaxel (Taxol)
  publication-title: Semin Oncol
  contributor:
    fullname: Rowinsky EK
– ident: e_1_2_5_92_1
  doi: 10.1089/ars.2012.5000
– ident: e_1_2_5_17_1
  doi: 10.1186/s40169-017-0148-3
– ident: e_1_2_5_20_1
  doi: 10.1161/CIRCULATIONAHA.110.950543
– ident: e_1_2_5_135_1
– ident: e_1_2_5_133_1
  doi: 10.1016/j.cardfail.2013.12.018
– ident: e_1_2_5_58_1
  doi: 10.1038/sj.bmt.1702234
– ident: e_1_2_5_138_1
  doi: 10.1200/JCO.2009.26.7294
– ident: e_1_2_5_16_1
  doi: 10.15420/cfr.2018.32.2
– ident: e_1_2_5_64_1
  doi: 10.1007/s11912-016-0521-1
– ident: e_1_2_5_129_1
  doi: 10.1002/ejhf.196
– ident: e_1_2_5_155_1
  doi: 10.2459/JCM.0000000000000379
– ident: e_1_2_5_99_1
  doi: 10.1016/j.ijrobp.2009.04.093
– ident: e_1_2_5_33_1
  doi: 10.1038/sj.onc.1210477
– ident: e_1_2_5_137_1
  doi: 10.1016/j.jacc.2012.09.035
– ident: e_1_2_5_27_1
  doi: 10.1161/CIR.0000000000000556
– ident: e_1_2_5_84_1
  doi: 10.1124/jpet.106.103846
– ident: e_1_2_5_203_1
  doi: 10.1200/JCO.2015.65.6603
– ident: e_1_2_5_162_1
  doi: 10.1373/clinchem.2015.241232
– ident: e_1_2_5_44_1
  doi: 10.1016/j.annonc.2020.09.010
– volume: 11
  start-page: 785
  year: 2017
  ident: e_1_2_5_100_1
  article-title: Recent advances in radiation oncology
  publication-title: Ecance Mmed Sci
  contributor:
    fullname: Garibaldi C
– ident: e_1_2_5_166_1
  doi: 10.1016/j.ijcard.2013.01.005
– ident: e_1_2_5_34_1
  doi: 10.1634/theoncologist.2008-0230
– ident: e_1_2_5_47_1
  doi: 10.1007/s10549-017-4460-9
– ident: e_1_2_5_63_1
  doi: 10.1186/2050-6511-15-47
– ident: e_1_2_5_125_1
  doi: 10.3892/etm.2011.305
– ident: e_1_2_5_172_1
  doi: 10.1177/1758835919864236
– ident: e_1_2_5_115_1
  doi: 10.1161/CIRCULATIONAHA.111.021774
– ident: e_1_2_5_19_1
  doi: 10.3389/fphar.2018.01262
– ident: e_1_2_5_32_1
  doi: 10.1016/S0959-8049(01)00230-1
– ident: e_1_2_5_116_1
  doi: 10.1152/japplphysiol.00148.2005
– ident: e_1_2_5_72_1
  doi: 10.4103/0973-1482.37412
– ident: e_1_2_5_38_1
  doi: 10.1200/JCO.2005.13.300
– ident: e_1_2_5_136_1
– ident: e_1_2_5_55_1
  doi: 10.1016/S0140-6736(00)02051-1
– ident: e_1_2_5_131_1
  doi: 10.1161/CIRCHEARTFAILURE.112.000055
– ident: e_1_2_5_206_1
  doi: 10.1002/ejhf.1631
– ident: e_1_2_5_158_1
  doi: 10.3892/ol.2016.4424
– ident: e_1_2_5_110_1
  doi: 10.1517/14656566.8.8.1039
– ident: e_1_2_5_118_1
  doi: 10.1158/1078-0432.CCR-09-0628
– ident: e_1_2_5_168_1
  doi: 10.1016/j.bbadis.2012.12.014
– ident: e_1_2_5_29_1
  doi: 10.2174/138920009788897975
– ident: e_1_2_5_163_1
  doi: 10.1161/01.CIR.0000130926.51766.CC
– ident: e_1_2_5_199_1
  doi: 10.1186/s13058-014-0446-2
– volume: 38
  start-page: 1032
  year: 2018
  ident: e_1_2_5_147_1
  article-title: Evaluation of changes in right ventricular myocardial mechanical properties in breast cancer patients receiving pirarubicin using three‐dimensional speckle tracking imaging
  publication-title: Nan Fang Yi Ke Da XueXueBao
  contributor:
    fullname: Wang Y
– ident: e_1_2_5_51_1
  doi: 10.1016/j.lfs.2018.12.018
– ident: e_1_2_5_23_1
  doi: 10.1016/j.yjmcc.2003.09.012
– ident: e_1_2_5_105_1
  doi: 10.1016/j.clon.2004.09.016
– ident: e_1_2_5_178_1
  doi: 10.3233/CBM-181301
– ident: e_1_2_5_76_1
  doi: 10.1097/01.COC.0000017526.55135.6D
– ident: e_1_2_5_123_1
  doi: 10.1002/cncr.21478
– ident: e_1_2_5_150_1
  doi: 10.1016/j.jcmg.2019.06.030
– ident: e_1_2_5_117_1
  doi: 10.3109/0284186X.2013.781673
– ident: e_1_2_5_170_1
  doi: 10.1158/1078-0432.CCR-10-1359
– ident: e_1_2_5_89_1
  doi: 10.1016/S1470-2045(05)70251-5
– ident: e_1_2_5_90_1
  doi: 10.1016/j.ijrobp.2007.05.034
– ident: e_1_2_5_194_1
  doi: 10.1007/s10549-015-3437-9
– ident: e_1_2_5_204_1
  doi: 10.1200/JCO.2007.15.9822
– ident: e_1_2_5_4_1
  doi: 10.3322/caac.21557
– volume: 35
  start-page: 2487
  year: 2015
  ident: e_1_2_5_108_1
  article-title: Radiation‐associated cardiac injury
  publication-title: Anticancer Res
  contributor:
    fullname: Eldabaje R
– ident: e_1_2_5_71_1
  doi: 10.1016/j.jccase.2017.03.009
– ident: e_1_2_5_151_1
  doi: 10.3109/1354750X.2015.1040839
– ident: e_1_2_5_196_1
  doi: 10.1080/10428194.2016.1231405
– ident: e_1_2_5_102_1
  doi: 10.1016/S0046-8177(96)90447-5
– ident: e_1_2_5_26_1
  doi: 10.1016/j.ijcard.2010.03.003
– ident: e_1_2_5_182_1
  doi: 10.1016/j.biopha.2018.11.042
– ident: e_1_2_5_87_1
  doi: 10.1093/annonc/mdt584
– ident: e_1_2_5_142_1
  doi: 10.1016/j.amjcard.2018.08.019
– ident: e_1_2_5_113_1
  doi: 10.1542/peds.2012-0727
– ident: e_1_2_5_183_1
  doi: 10.1097/HCO.0000000000000050
– ident: e_1_2_5_78_1
  doi: 10.1177/030089168206800609
– ident: e_1_2_5_205_1
  doi: 10.1161/CIR.0000000000000679
– ident: e_1_2_5_126_1
  doi: 10.1016/j.jacc.2013.02.072
– ident: e_1_2_5_62_1
  doi: 10.2174/1568011023354146
– ident: e_1_2_5_5_1
  doi: 10.7326/M19-2125
– ident: e_1_2_5_41_1
  doi: 10.1093/annonc/mdq096
– ident: e_1_2_5_169_1
  doi: 10.1093/eurheartj/ehw128
– volume: 133
  start-page: 38
  year: 2016
  ident: e_1_2_5_198_1
  article-title: American Heart Association Statistics Committee; Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics‐2016 Update: A Report From the American Heart Association
  publication-title: Circulation
  contributor:
    fullname: Writing Group Members
– ident: e_1_2_5_173_1
  doi: 10.1007/s00280-015-2874-9
– ident: e_1_2_5_190_1
  doi: 10.2174/0929867325666180327092639
– ident: e_1_2_5_21_1
  doi: 10.1016/j.cell.2004.07.017
– ident: e_1_2_5_43_1
– ident: e_1_2_5_12_1
  doi: 10.1093/ehjci/jeu192
– ident: e_1_2_5_59_1
  doi: 10.1021/bi00700a012
– ident: e_1_2_5_191_1
  doi: 10.1016/j.ygyno.2011.11.022
– ident: e_1_2_5_24_1
  doi: 10.1093/eurheartj/ehw211
– ident: e_1_2_5_68_1
  doi: 10.15420/icr.2019.12
– ident: e_1_2_5_185_1
  doi: 10.1038/nature09783
– ident: e_1_2_5_11_1
  doi: 10.1200/JCO.2005.05.827
– volume: 12
  start-page: 23
  year: 1998
  ident: e_1_2_5_79_1
  article-title: Taxanes in adjuvant and neoadjuvant therapies for breast cancer
  publication-title: Oncology (Williston Park)
  contributor:
    fullname: O'Leary J
– ident: e_1_2_5_49_1
  doi: 10.1016/S0025-6196(11)60896-3
– ident: e_1_2_5_25_1
  doi: 10.1016/j.annonc.2019.10.023
– ident: e_1_2_5_132_1
  doi: 10.1016/j.ejca.2013.04.030
– ident: e_1_2_5_143_1
  doi: 10.1186/s12885-018-4935-z
– volume: 8
  start-page: I51
  year: 2002
  ident: e_1_2_5_77_1
  article-title: Cardiotoxicity following different doses and schedules of 5‐fluorouracil administration for malignancy—a survey of 427 patients
  publication-title: Med Sci Monit
  contributor:
    fullname: Tsavaris N
– ident: e_1_2_5_180_1
  doi: 10.1093/cvr/cvq148
– ident: e_1_2_5_186_1
  doi: 10.1016/j.taap.2014.10.006
– volume: 53
  start-page: 320
  year: 2012
  ident: e_1_2_5_69_1
  article-title: Capecitabine may induce coronary artery vasospasm
  publication-title: Hellenic J Cardiol
  contributor:
    fullname: Tsiamis E
– ident: e_1_2_5_103_1
  doi: 10.1093/jrr/rry029
– ident: e_1_2_5_197_1
  doi: 10.1161/CIRCULATIONAHA.115.020406
– ident: e_1_2_5_3_1
  doi: 10.2147/BCTT.S176070
– ident: e_1_2_5_46_1
  doi: 10.1016/j.clinthera.2009.11.029
– ident: e_1_2_5_167_1
  doi: 10.1080/01926230500519816
– ident: e_1_2_5_18_1
  doi: 10.1093/nar/gkn774
– ident: e_1_2_5_83_1
  doi: 10.1517/14740338.2.1.59
– ident: e_1_2_5_10_1
  doi: 10.1016/j.mayocp.2014.05.013
SSID ssj0001561524
Score 2.3189933
SecondaryResourceType review_article
Snippet The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years,...
Abstract The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years,...
Abstract The most common cancer diagnosis in female population is breast cancer, which affects every year about 2.0 million women worldwide. In recent years,...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 2397
SubjectTerms Antibiotics
Apoptosis
Biomarkers
Breast cancer
Cancer therapies
Cardiac arrhythmia
Cardiomyocytes
Cardiotoxicity
Chemotherapy
Drug dosages
Epidermal growth factor
Genetic engineering
Heart failure
Hormone replacement therapy
Kinases
Mammography
Monoclonal antibodies
Myocarditis
Oncological treatment
Radiation therapy
Review
Reviews
Womens health
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JSsRAEC3Eg3gRd-NGg56EaNJbkqOKwyDoScFbk95QwYzMRNC_t7oThxkUvXhL0tk6rzr1iry8BjjOjNQMeWzKjdcpxwIDxxwNIkddaiSwJTXhb-SbWzm859cP4mFmqq-gCevsgbsHd5Y7DDspBeZRzTNblQbDzDldZNwF7-749s2qmWKq_z8YExOf-pHSM_fo6SkWZCGLzGSgaNT_E7v8LpKcJa8x-wxWYaWnjeS8u901WHDNOizd9B_GN-D93D6_ISluiQ4q85aYgOaYTHXkE9wSlKft6B0PaT9I3VjyEidCI90s0hMy8sS6Nmqzmtj-2vs74Sq2xRPUhsyp0DfhfnB1dzlM-0kVUiPKXKRF6aWwxsi69o5xq7WuCuHCBzmJpY9gXHjNcmss1io4OLnNq5oyU3rLfeEt24LFZtS4HSAIMdJLqjHhWW4R9IznBvmMt75mzNoEjr4etHrtvDNU55JMVYBDRTgSuAgYTPcIftdxA0aB6qNA_RUFCex_Iaj6QThRWC0JiZ2gMoHtDszpVRirhKBZkUAxB_Pcbcy3NE-P0X67xNcgr1gCJzEgfumauhoOaFza_Y9O7sEyDYqaKD_ch8V2_OYOkBK1-jBG_ye6OgkB
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Za9wwEB7SDZS-hDbp4VwI2qeCG1uHj6eShF2WQEIpCeRNWFfTQu3NrgPJv89I1m6ytOTNtnzI_qTRN9LnGYAvmS4UQx6bcu1UytHBwD5HvchRVQoJbEW1_xv5_KKYXvGza3EdJ9wWUVa5tInBUJtO-znyI6S-oig58u_vs9vUZ43yq6sxhcYr2KToKWQj2DwZX_z4-TTLgvRAUL6KS0qP7I2j39Ax86PJs5EoBOz_H8v8Vyz5nMSGUWjyFrYifSTHA97vYMO22_D6PC6Q78D9sflzh-S4J8qrzXuiPapzstKTL_CIV6D23T1e0j-QpjXkb0iIRoZs0gvSOWJsHzRabSifxThPuItl4QaNJmtq9PdwNRlfnk7TmFwh1aLKRVpWrhBG66JpnGXcKKXqUli_MFegCyQYF06x3GiDPgt2Um7yuqFMV85wVzrDPsCo7Vr7CQhCjTSTKhz4DDcIfsZzjbzGGdcwZkwCn5cfWs6GGBpyiJZMpYdDBjgSOPEYrM7wca_DgW7-S8ZuJHOLRghrh6xK8czUlUajY60qM259JPcE9pcIytgZF_Kp6STwcQBz9RTGaiFoViZQrsG8Vo31kvb3TQjDXaE55DVL4GtoEC-8mhxPJzRs7b5cvz14Q71mJggM92HUz-_sAZKeXh3Glv0IBjUDXQ
  priority: 102
  providerName: ProQuest
– databaseName: Wiley-Blackwell Open Access Collection
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS9xAGP2wK5S-SKvVxmoZ0KdCNJlLLuCListSUHxQ8G3I3KpCs7IbYf33fjPJZhsqQt-STO5nvpnzTU7OABwmOlMMeWzMtVMxxwQDY456kaMqFBLYgmr_N_LlVTa55b_uxN0anCz_hWn9IfoBNx8Zob32AV6p-fHKNNTeO3qEGVYmPsC6t4zxzvmUX69GWJAaiDCrLU2EiAV2hb0_KT1eHT7okYJx_1ts81_R5N9kNvRG48-w0dFIctri_gXWbL0JHy-7D-VbsDg1j89IkhuivOq8IdqjOyO9rnyOW7wStZku8JDmhVS1IX_CxGiknVV6TqaOGNsErVYdyp86vydcxbJwgkqTgSr9K9yOL27OJ3E3yUKsRZGKOC9cJozWWVU5y7hRSpW5sP4DXYapkGBcOMVSow3mLhis3KRlRZkunOEud4Ztw6ie1vYbEIQc6SZV2AEabrASJDzVyG-ccRVjxkRwsHzR8qn10pCtazKVHg4Z4IjgzGPQ7-H9r8OG6ey37MJJphYbI7w7ZFeKJ6YsNDY-1qo84dY7ukewt0RQdkE5l5g9iQwfgmYR7LRg9ldhrBSCJnkE-QDmwW0MS-qH-2DHXWCzyEsWwc9QId55NHkxGdOwtPs_O3-HT9QraYLscA9GzezZ7iMVatSPUONfAbVeBFM
  priority: 102
  providerName: Wiley-Blackwell
Title Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fehf2.13365
https://www.ncbi.nlm.nih.gov/pubmed/33955207
https://www.proquest.com/docview/2555674626
https://pubmed.ncbi.nlm.nih.gov/PMC8318493
https://doaj.org/article/1e031665993b40d98c042eeb704e0514
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB7iFEovJelTTWIW2lNBtrUPPY5JsDEFB1Ma8G3RvpqUWja2Aum_z-xKMjYNPfQiJK0eK32zu99I384AfBnpVDHksTHXTsUcHQxsc9SLHFWukMDmVPvZyLObdHrLvy3E4ghENxcmiPa1uh9Uv5eD6v4uaCvXSz3sdGLD-ew6R0PkBRv2oIcGuueit1ODcUziu1CkdGjvHB2gL5b6NDWMFUJQnz12bxwK4fqf45h_SyX3KWwYgyYn8Lolj-SyqeQpHNnqDbyctb_H38Ljpfn1gNS4JsprzWuiPaYbslOTb3GP15_Wq0c8pf5DysqQZUiHRppc0luycsTYOii0qlC-bqM84SaWhQuUmhxo0d_B7WT843oat6kVYi3yRMRZ7lJhtE7L0lnGjVKqyIT1v-VSdIAE48Iplhht0GPBJspNUpSU6dwZ7jJn2Hs4rlaV_QgEgUaSSRUOe4YbhH7EE42sxhlXMmZMBJ-7Fy3XTQQN2cRKptIjIwMyEVx5DHZH-KjXYcdq81O22MvEYheEtUNOpfjIFLnGLsdalY249XHcIzjvEJRtU9xK9JlEig9B0wg-NGDu7tIZQwTZAcwH1TgsQZsMQbhbG4zgazCIfzyaHE8nNKx9-u_bnMEr6sU0QXl4Dsf15sFeIBuqVR96lM9xmS2yPry4Gt_Mv_fDl4V-aBdPdc8PQQ
link.rule.ids 230,315,730,783,787,867,888,2109,11574,12068,21400,27936,27937,31731,33756,43322,43817,46064,46488,50826,50935,53804,53806,74073,74630
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bb9MwFD6CTQJeEHfCNrAET0hhiS-5PKFtalVgrRDapL1Z8W0DiaS0mTT-_Y4dt1sF2lsbt43bzz7-jv31OwAfMl0ohjw25dqplGOCgXOOepGjqhQS2Ipq_2_k6ayYnPKvZ-Isbrgto6xyFRNDoDad9nvk-0h9RVFy5N-f539SXzXKn67GEhr3YdtbVWHytX04mn3_cbPLgvRAUL72JaX79sLRT5iY-dXk1koUDPv_xzL_FUveJrFhFRo_gceRPpKDAe-ncM-2z-DBNB6QP4erA_PrEslxT5RXm_dEe1QXZK0nX-IVr0Dtuyt8S_-XNK0hv0NBNDJUk16SzhFj-6DRakP7PPo84VNsCx_QaLKhRn8Bp-PRydEkjcUVUi2qXKRl5QphtC6axlnGjVKqLoX1B3MFpkCCceEUy402mLPgJOUmrxvKdOUMd6Uz7CVstV1rXwNBqJFmUoULn-EGwc94rpHXOOMaxoxJ4P3qh5bzwUNDDm7JVHo4ZIAjgUOPwfoV3vc6XOgW5zJOI5lbDELYO2RVimemrjQGHWtVmXHrndwT2F0hKONkXMqboZPAqwHM9V0Yq4WgWZlAuQHzRjc2W9qfF8GGu8JwyGuWwMcwIO74anI0GdPw6M3d_XsHDycn02N5_GX2bQceUa-fCWLDXdjqF5d2DwlQr97GUX4NfPoGVw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Zb9QwEB7BVqp4qbgJFLAET0hhEx85nlALu1qOripEpb5Z8dWCRLLdTaXy7xk73m1XoL4lcQ4n33j82f4yA_A204ViyGNTrp1KOQ4wsM1RL3JUlUICW1Ht_0Y-mhezE_7lVJxG_dMqyirXPjE4atNpP0c-RuoripIj_x67KIs4_jT9sLhIfQYpv9Ia02nchR08jWUj2DmczI-_X8-4IFUQlG9ilNKxPXf0PQ7SfM9yo1cKwfv_xzj_FU7eJLShR5reh71IJcnBgP0DuGPbh7B7FBfLH8HVgfl1iUS5J8orz3uiPcJLstGWr_CIV6P23RVe0v8hTWvI75AcjQyZpVekc8TYPui12lC-iDGfcBfLwg0aTbaU6Y_hZDr58XGWxkQLqRZVLtKycoUwWhdN4yzjRilVl8L6RboCh0OCceEUy402uf-0FTd53VCmK2e4K51hT2DUdq19BgRhR8pJFXaChhs0hIznGjmOM65hzJgE3qw_tFwM8TTkEDmZSg-HDHAkcOgx2JzhY2CHA93yTMYmJXOLDglrhwxL8czUlUYHZK0qM259VPcE9tcIytgwV_LajBJ4OoC5eQpjtRA0KxMot2DeqsZ2SfvzPITkrtA18pol8C4YxC2vJiezKQ1bz2-v32vYRQOX3z7Pv76Ae9RLaYLucB9G_fLSvkQu1KtX0cj_ApcPCoU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adjuvant+breast+cancer+treatments+cardiotoxicity+and+modern+methods+of+detection+and+prevention+of+cardiac+complications&rft.jtitle=ESC+Heart+Failure&rft.au=Bikiewicz%2C+Agata&rft.au=Banach%2C+Maciej&rft.au=von+Haehling%2C+Stephan&rft.au=Maciejewski%2C+Marek&rft.date=2021-08-01&rft.issn=2055-5822&rft.eissn=2055-5822&rft.volume=8&rft.issue=4&rft.spage=2397&rft.epage=2418&rft_id=info:doi/10.1002%2Fehf2.13365&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_ehf2_13365
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2055-5822&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2055-5822&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2055-5822&client=summon